Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis.

Kavouridis VK, Boaro A, Dorr J, Cho EY, Iorgulescu JB, Reardon DA, Arnaout O, Smith TR.

J Neurosurg. 2019 Oct 25:1-11. doi: 10.3171/2019.6.JNS19972. [Epub ahead of print]

PMID:
31653812
2.

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.

Guièze R, Liu VM, Rosebrock D, Jourdain AA, Hernández-Sánchez M, Martinez Zurita A, Sun J, Ten Hacken E, Baranowski K, Thompson PA, Heo JM, Cartun Z, Aygün O, Iorgulescu JB, Zhang W, Notarangelo G, Livitz D, Li S, Davids MS, Biran A, Fernandes SM, Brown JR, Lako A, Ciantra ZB, Lawlor MA, Keskin DB, Udeshi ND, Wierda WG, Livak KJ, Letai AG, Neuberg D, Harper JW, Carr SA, Piccioni F, Ott CJ, Leshchiner I, Johannessen CM, Doench J, Mootha VK, Getz G, Wu CJ.

Cancer Cell. 2019 Oct 14;36(4):369-384.e13. doi: 10.1016/j.ccell.2019.08.005. Epub 2019 Sep 19.

PMID:
31543463
3.

Predictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomas.

Harary M, Kavouridis VK, Torre M, Zaidi HA, Chukwueke UN, Reardon DA, Smith TR, Iorgulescu JB.

Neuro Oncol. 2019 Sep 20. pii: noz168. doi: 10.1093/neuonc/noz168. [Epub ahead of print]

PMID:
31538193
4.

Survival and prognostic factors in surgically treated brain metastases.

Kavouridis VK, Harary M, Hulsbergen AFC, Lo YT, Reardon DA, Aizer AA, Iorgulescu JB, Smith TR.

J Neurooncol. 2019 Jun;143(2):359-367. doi: 10.1007/s11060-019-03171-6. Epub 2019 Apr 16.

PMID:
30989623
5.

Efficacy and safety of immune checkpoint blockade for brain metastases.

Harary M, Reardon DA, Iorgulescu JB.

CNS Oncol. 2019 Jun;8(2):CNS33. doi: 10.2217/cns-2018-0018. Epub 2019 Mar 11. No abstract available.

6.

The Misclassification of Diffuse Gliomas: Rates and Outcomes.

Iorgulescu JB, Torre M, Harary M, Smith TR, Aizer AA, Reardon DA, Barnholtz-Sloan JS, Perry A.

Clin Cancer Res. 2019 Apr 15;25(8):2656-2663. doi: 10.1158/1078-0432.CCR-18-3101. Epub 2019 Jan 11.

PMID:
30635340
7.

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial.

Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, Oliveira G, Giobbie-Hurder A, Felt K, Gjini E, Shukla SA, Hu Z, Li L, Le PM, Allesøe RL, Richman AR, Kowalczyk MS, Abdelrahman S, Geduldig JE, Charbonneau S, Pelton K, Iorgulescu JB, Elagina L, Zhang W, Olive O, McCluskey C, Olsen LR, Stevens J, Lane WJ, Salazar AM, Daley H, Wen PY, Chiocca EA, Harden M, Lennon NJ, Gabriel S, Getz G, Lander ES, Regev A, Ritz J, Neuberg D, Rodig SJ, Ligon KL, Suvà ML, Wucherpfennig KW, Hacohen N, Fritsch EF, Livak KJ, Ott PA, Wu CJ, Reardon DA.

Nature. 2019 Jan;565(7738):234-239. doi: 10.1038/s41586-018-0792-9. Epub 2018 Dec 19.

8.

Spindle cell oncocytoma of the pituitary gland.

Giantini Larsen AM, Cote DJ, Zaidi HA, Bi WL, Schmitt PJ, Iorgulescu JB, Miller MB, Smith TR, Lopes MB, Jane JA, Laws ER.

J Neurosurg. 2018 Oct 19;131(2):517-525. doi: 10.3171/2018.4.JNS18211.

9.

Acquired mechanisms of immune escape in cancer following immunotherapy.

Iorgulescu JB, Braun D, Oliveira G, Keskin DB, Wu CJ.

Genome Med. 2018 Nov 22;10(1):87. doi: 10.1186/s13073-018-0598-2.

10.

Predicting Readmission and Reoperation for Benign Cranial Nerve Neoplasms: A Nationwide Analysis.

Gupta S, Ahmed AK, Bi WL, Dawood HY, Iorgulescu JB, Corrales CE, Dunn IF, Smith TR.

World Neurosurg. 2019 Jan;121:e223-e229. doi: 10.1016/j.wneu.2018.09.081. Epub 2018 Sep 25.

PMID:
30261394
11.

Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies.

Dobry AS, Zogg CK, Hodi FS, Smith TR, Ott PA, Iorgulescu JB.

Cancer Immunol Immunother. 2018 Dec;67(12):1833-1844. doi: 10.1007/s00262-018-2241-x. Epub 2018 Sep 6.

PMID:
30191256
12.

Immunotherapy for glioblastoma: going viral.

Iorgulescu JB, Reardon DA, Chiocca EA, Wu CJ.

Nat Med. 2018 Aug;24(8):1094-1096. doi: 10.1038/s41591-018-0142-3. No abstract available.

13.

Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort.

Iorgulescu JB, Harary M, Zogg CK, Ligon KL, Reardon DA, Hodi FS, Aizer AA, Smith TR.

Cancer Immunol Res. 2018 Sep;6(9):1039-1045. doi: 10.1158/2326-6066.CIR-18-0067. Epub 2018 Jul 12.

14.

Non-meningothelial meningeal tumours with meningioangiomatosis-like pattern of spread.

Iorgulescu JB, Ferris S, Agarwal A, Casavilca Zambrano S, Hill DA, Schmidt R, Perry A.

Neuropathol Appl Neurobiol. 2018 Dec;44(7):743-746. doi: 10.1111/nan.12481. Epub 2018 Apr 10. No abstract available.

PMID:
29495087
15.

Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.

Iorgulescu JB, Van Ziffle J, Stevers M, Grenert JP, Bastian BC, Chavez L, Stichel D, Buchhalter I, Samuel D, Nicolaides T, Banerjee A, Mueller S, Gupta N, Tihan T, Bollen AW, Northcott PA, Kool M, Pfister S, Korshunov A, Perry A, Solomon DA.

Acta Neuropathol. 2018 Apr;135(4):635-638. doi: 10.1007/s00401-018-1819-x. Epub 2018 Feb 12. No abstract available.

16.

Recent advances in intradural spinal tumors.

Abd-El-Barr MM, Huang KT, Moses ZB, Iorgulescu JB, Chi JH.

Neuro Oncol. 2018 May 18;20(6):729-742. doi: 10.1093/neuonc/nox230. Review.

17.

Stabilization of Tumor-Associated Craniovertebral Junction Instability: Indications, Operative Variables, and Outcomes.

Zuckerman SL, Kreines F, Powers A, Iorgulescu JB, Elder JB, Bilsky MH, Laufer I.

Neurosurgery. 2017 Aug 1;81(2):251-258. doi: 10.1093/neuros/nyx070.

PMID:
28368478
18.

Identifying the Long-Term Role of Inducible Nitric Oxide Synthase after Contusive Spinal Cord Injury Using a Transgenic Mouse Model.

Maggio DM, Singh A, Iorgulescu JB, Bleicher DH, Ghosh M, Lopez MM, Tuesta LM, Flora G, Dietrich WD, Pearse DD.

Int J Mol Sci. 2017 Jan 25;18(2). pii: E245. doi: 10.3390/ijms18020245.

19.

Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis.

Karhade AV, Fandino L, Gupta S, Cote DJ, Iorgulescu JB, Broekman ML, Aglio LS, Dunn IF, Smith TR.

J Neurooncol. 2017 Jan;131(1):59-67. doi: 10.1007/s11060-016-2262-2. Epub 2016 Nov 18.

PMID:
27864707
20.

Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial.

Xu R, Shimizu F, Hovinga K, Beal K, Karimi S, Droms L, Peck KK, Gutin P, Iorgulescu JB, Kaley T, DeAngelis L, Pentsova E, Nolan C, Grommes C, Chan T, Bobrow D, Hormigo A, Cross JR, Wu N, Takebe N, Panageas K, Ivy P, Supko JG, Tabar V, Omuro A.

Clin Cancer Res. 2016 Oct 1;22(19):4786-4796. Epub 2016 May 6.

21.

The limited capacity of malignant glioma-derived exosomes to suppress peripheral immune effectors.

Iorgulescu JB, Ivan ME, Safaee M, Parsa AT.

J Neuroimmunol. 2016 Jan 15;290:103-8. doi: 10.1016/j.jneuroim.2015.11.025. Epub 2015 Nov 28.

PMID:
26711578
22.

Acute Putrescine Supplementation with Schwann Cell Implantation Improves Sensory and Serotonergic Axon Growth and Functional Recovery in Spinal Cord Injured Rats.

Iorgulescu JB, Patel SP, Louro J, Andrade CM, Sanchez AR, Pearse DD.

Neural Plast. 2015;2015:186385. doi: 10.1155/2015/186385. Epub 2015 Oct 13.

23.

Sex, Age, Anatomic Location, and Extent of Resection Influence Outcomes in Children With High-grade Glioma.

McCrea HJ, Bander ED, Venn RA, Reiner AS, Iorgulescu JB, Puchi LA, Schaefer PM, Cederquist G, Greenfield JP.

Neurosurgery. 2015 Sep;77(3):443-52; discussion 452-3. doi: 10.1227/NEU.0000000000000845.

PMID:
26083157
24.

Endoscopic endonasal resection of skull base chondrosarcomas: technique and early results.

Moussazadeh N, Kulwin C, Anand VK, Ting JY, Gamss C, Iorgulescu JB, Tsiouris AJ, Cohen-Gadol AA, Schwartz TH.

J Neurosurg. 2015 Apr;122(4):735-42. doi: 10.3171/2014.11.JNS14827. Epub 2015 Jan 16.

PMID:
25594323
25.

Incidence, Timing, and Predictors of Delayed Shunting for Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage.

Walcott BP, Iorgulescu JB, Stapleton CJ, Kamel H.

Neurocrit Care. 2015 Aug;23(1):54-8. doi: 10.1007/s12028-014-0072-y.

PMID:
25519720
26.

Risk factors for postoperative cerebrospinal fluid leak and meningitis after expanded endoscopic endonasal surgery.

Ivan ME, Iorgulescu JB, El-Sayed I, McDermott MW, Parsa AT, Pletcher SD, Jahangiri A, Wagner J, Aghi MK.

J Clin Neurosci. 2015 Jan;22(1):48-54. doi: 10.1016/j.jocn.2014.08.009. Epub 2014 Nov 22. Review.

PMID:
25439754
27.

A review of stereotactic radiosurgery practice in the management of skull base meningiomas.

Vera E, Iorgulescu JB, Raper DM, Madhavan K, Lally BE, Morcos J, Elhammady S, Sherman J, Komotar RJ.

J Neurol Surg B Skull Base. 2014 Jun;75(3):152-8. doi: 10.1055/s-0033-1354747. Epub 2014 Mar 12.

28.

The incidence and patterns of hardware failure after separation surgery in patients with spinal metastatic tumors.

Amankulor NM, Xu R, Iorgulescu JB, Chapman T, Reiner AS, Riedel E, Lis E, Yamada Y, Bilsky M, Laufer I.

Spine J. 2014 Sep 1;14(9):1850-9. doi: 10.1016/j.spinee.2013.10.028. Epub 2013 Nov 8.

PMID:
24216397
29.

Benign notochordal cell tumors of the spine: natural history of 8 patients with histologically confirmed lesions.

Iorgulescu JB, Laufer I, Hameed M, Boland P, Yamada Y, Lis E, Bilsky M.

Neurosurgery. 2013 Sep;73(3):411-6. doi: 10.1227/01.neu.0000431476.94783.c6.

PMID:
23719057
30.

Comparison of navigated versus non-navigated pedicle screw placement in 260 patients and 1434 screws: screw accuracy, screw size, and the complexity of surgery.

Luther N, Iorgulescu JB, Geannette C, Gebhard H, Saleh T, Tsiouris AJ, Härtl R.

J Spinal Disord Tech. 2015 Jun;28(5):E298-303. doi: 10.1097/BSD.0b013e31828af33e.

PMID:
23511642
31.

Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients.

Laufer I, Iorgulescu JB, Chapman T, Lis E, Shi W, Zhang Z, Cox BW, Yamada Y, Bilsky MH.

J Neurosurg Spine. 2013 Mar;18(3):207-14. doi: 10.3171/2012.11.SPINE12111. Epub 2013 Jan 22.

32.

The role of radiotherapy following gross-total resection of atypical meningiomas.

Komotar RJ, Iorgulescu JB, Raper DM, Holland EC, Beal K, Bilsky MH, Brennan CW, Tabar V, Sherman JH, Yamada Y, Gutin PH.

J Neurosurg. 2012 Oct;117(4):679-86. doi: 10.3171/2012.7.JNS112113. Epub 2012 Aug 24.

PMID:
22920955
33.

The management of incidental low-grade gliomas using magnetic resonance imaging: systematic review and optimal treatment paradigm.

Shah AH, Madhavan K, Heros D, Raper DM, Iorgulescu JB, Lally BE, Komotar RJ.

Neurosurg Focus. 2011 Dec;31(6):E12. doi: 10.3171/2011.9.FOCUS11219. Review.

PMID:
22133169
34.

Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding.

Siu A, Wind JJ, Iorgulescu JB, Chan TA, Yamada Y, Sherman JH.

Acta Neurochir (Wien). 2012 Feb;154(2):191-201; discussion 201. doi: 10.1007/s00701-011-1228-6. Epub 2011 Dec 1. Review.

PMID:
22130634
35.

Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy.

Komotar RJ, Raper DM, Starke RM, Iorgulescu JB, Gutin PH.

J Neurosurg. 2011 Sep;115(3):483-90. doi: 10.3171/2011.4.JNS101585. Epub 2011 Jun 3. Review.

PMID:
21639698
36.

The value of intraoperative electrocorticography in surgical decision making for temporal lobe epilepsy with normal MRI.

Luther N, Rubens E, Sethi N, Kandula P, Labar DR, Harden C, Perrine K, Christos PJ, Iorgulescu JB, Lancman G, Schaul NS, Kolesnik DV, Nouri S, Dawson A, Tsiouris AJ, Schwartz TH.

Epilepsia. 2011 May;52(5):941-8. doi: 10.1111/j.1528-1167.2011.03061.x. Epub 2011 Apr 11.

37.

Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells.

Pearse DD, Tian RX, Nigro J, Iorgulescu JB, Puzis L, Jaimes EA.

Am J Physiol Renal Physiol. 2008 May;294(5):F1094-100. doi: 10.1152/ajprenal.00458.2007. Epub 2008 Mar 12.

Supplemental Content

Loading ...
Support Center